Literature DB >> 3535865

Histological, cytological and immunological analyses are complementary for the detection of neuroblastoma cells in bone marrow.

M C Favrot, D Frappaz, O Maritaz, I Philip, B Fontaniere, O Gentilhomme, C Bailly, J M Zucker, J C Gentet, J Kemshead.   

Abstract

On 80 occasions 4 iliac biopsy trephines and 4 iliac aspirations were performed in 37 children with neuroblastoma at various stages of the disease. In 38 of these procedures, tumour cells were detected. In 24% of cases, both trephines and aspirates were positive, whereas in 63% neuroblastoma cells were detected only on the trephines and in 13% only on the aspirates. In addition, in 37% of the stagings, only one out of the 8 investigations was abnormal. Only in one of 33 pathological cases, was BM involvement diagnosed on trephine imprint. No involvement was ever observed on tibial and sternal aspirates without iliac involvement. Immunological studies with two monoclonal antibodies HSAN 1-2 and UJ13A were performed on 56 occasions. Cytohistological and immunological studies were concordant in 39. In 3 studies, the antigens recognized by the two monoclonal antibodies were not expressed by the initial tumour and in 3 additional studies immunological results were falsely negative; but in 11 cases monoclonal antibodies identified residual malignancy despite normal cytohistology. From this study, biopsies appear more helpful to detect malignant cells than aspirates. Immunological staining clearly leads to a better definition of tumour cells in aspirates.

Entities:  

Mesh:

Year:  1986        PMID: 3535865      PMCID: PMC2001485          DOI: 10.1038/bjc.1986.220

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  10 in total

1.  Purged autologous bone marrow transplantation in 25 cases of very poor prognosis neuroblastoma.

Authors:  T Philip; J L Bernard; J M Zucker; G Souillet; M Favrot; I Philip; P Bordigoni; J P Lutz; E Plouvier; P Carton
Journal:  Lancet       Date:  1985-03-09       Impact factor: 79.321

2.  Metastatic neuroblastoma managed by supralethal therapy and bone marrow reconstitution (BMRc). Results of a four-institution Children's Cancer Study Group pilot study.

Authors:  G J D'Angio; C August; W Elkins; A E Evans; R Seeger; C Lenarsky; S Feig; J Wells; N Ramsay; T Kim
Journal:  Prog Clin Biol Res       Date:  1985

3.  The value of bone marrow trephine biopsy in the diagnosis of metastatic neuroblastoma.

Authors:  B Bostrom; M E Nesbit; R D Brunning
Journal:  Am J Pediatr Hematol Oncol       Date:  1985

4.  Distinct reactivity of Burkitt's lymphoma cell lines with eight monoclonal antibodies correlated with the ethnic origin.

Authors:  M C Favrot; I Philip; T Philip; J Portoukalian; J F Doré; G M Lenoir
Journal:  J Natl Cancer Inst       Date:  1984-10       Impact factor: 13.506

5.  Use of panels of monoclonal antibodies in the differential diagnosis of neuroblastoma and lymphoblastic disorders.

Authors:  J T Kemshead; A Goldman; J Fritschy; J S Malpas; J Pritchard
Journal:  Lancet       Date:  1983-01-01       Impact factor: 79.321

6.  Advanced neuroblastoma: improved response rate using a multiagent regimen (OPEC) including sequential cisplatin and VM-26.

Authors:  E A Shafford; D W Rogers; J Pritchard
Journal:  J Clin Oncol       Date:  1984-07       Impact factor: 44.544

7.  Biological characterization and clinical applications of a monoclonal antibody recognizing an antigen restricted to neuroectodermal tissues.

Authors:  P M Allan; J A Garson; E I Harper; U Asser; H B Coakham; B Brownell; J T Kemshead
Journal:  Int J Cancer       Date:  1983-05-15       Impact factor: 7.396

8.  Detection of bone marrow invasion by neuroblastoma is improved by sampling at two sites with both aspirates and trephine biopsies.

Authors:  I M Franklin; J Pritchard
Journal:  J Clin Pathol       Date:  1983-11       Impact factor: 3.411

9.  Highly selective recognition of human neuroblastoma cells by mouse monoclonal antibody to a cytoplasmic antigen.

Authors:  N Gross; D Beck; S Carrel; M Munoz
Journal:  Cancer Res       Date:  1986-06       Impact factor: 12.701

10.  Routine immunofluorescent and histochemical analysis of bone marrow involvement of lymphoma/leukaemia: the use of cryostat sections.

Authors:  M Chilosi; G Pizzolo; L Fiore-Donati; M Bofill; G Janossy
Journal:  Br J Cancer       Date:  1983-12       Impact factor: 7.640

  10 in total
  13 in total

Review 1.  Micrometastases in neuroblastoma: are they clinically important?

Authors:  S A Burchill
Journal:  J Clin Pathol       Date:  2004-01       Impact factor: 3.411

2.  Detection of bone marrow metastases in neuroblastoma using a short term tissue culture technique.

Authors:  J A Adams; A M Kelsey; T F Carr; R F Stevens; P Morris-Jones
Journal:  J Clin Pathol       Date:  1992-05       Impact factor: 3.411

3.  Routine histological compared with immunohistological examination of bone marrow trephine biopsy specimens in disseminated neuroblastoma.

Authors:  M M Reid; J P Wallis; A G McGuckin; A D Pearson; A J Malcolm
Journal:  J Clin Pathol       Date:  1991-06       Impact factor: 3.411

4.  Immunocytochemical detection of neuroblastoma cells infiltrating clinical bone marrow samples.

Authors:  D Beck; O Maritaz; N Gross; M Favrot; N Vultier; C Bailly; I Villa; O Gentilhomme; T Philip
Journal:  Eur J Pediatr       Date:  1988-08       Impact factor: 3.183

5.  Immunocytochemical examination of bone marrow in disseminated neuroblastoma.

Authors:  P J Carey; L Thomas; G Buckle; M M Reid
Journal:  J Clin Pathol       Date:  1990-01       Impact factor: 3.411

6.  Lack of evidence of osteo-medullary metastases at diagnosis in patients with high grade gliomas.

Authors:  D Frappaz; A Jouvet; G S Pierre; F Giammarile; J Guyotat; R Deruty; E Jouanneau; D Ranchère-Vince
Journal:  J Neurooncol       Date:  2001-05       Impact factor: 4.130

7.  A comparison of iodine-123 meta-iodobenzylguanidine scintigraphy and single bone marrow aspiration biopsy in the diagnosis and follow-up of 26 children with neuroblastoma.

Authors:  K Osmanagaoglu; M Lippens; Y Benoit; E Obrie; K Schelstraete; M Simons
Journal:  Eur J Nucl Med       Date:  1993-12

8.  Monoclonal antibodies for detecting bone marrow invasion by neuroblastoma.

Authors:  D W Rogers; J G Treleaven; J T Kemshead; J Pritchard
Journal:  J Clin Pathol       Date:  1989-04       Impact factor: 3.411

9.  Immunological detection of neuroblastoma cells in bone marrow harvested for autologous transplantation.

Authors:  V Combaret; M C Favrot; B Kremens; I Philip; C Bailly; B Fontaniere; O Gentilhomme; F Chauvin; J M Zucker; J L Bernard
Journal:  Br J Cancer       Date:  1989-06       Impact factor: 7.640

10.  Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force.

Authors:  K Beiske; S A Burchill; I Y Cheung; E Hiyama; R C Seeger; S L Cohn; A D J Pearson; K K Matthay
Journal:  Br J Cancer       Date:  2009-04-28       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.